Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
What explains functioning from the perspective of people with multiple sclerosis?
Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic.
Cognitive function in multiple sclerosis: a subcortical pattern of neuropsychological impairment?
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
Intracellular signaling pathway regulation of myelination and remyelination in the CNS.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Neuroimaging and cognition using functional near infrared spectroscopy (fNIRS) in multiple sclerosis.
Tumefactive demyelinating lesions: A Clinicopathological correlative study.
Hemianopia and visual loss due to progressive multifocal leukoencephalopathy in natalizumab-treated multiple sclerosis.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
Epileptic Seizures in Early-onset Multiple Sclerosis.
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.
Street-experienced peripheral B cells traffic to the brain.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
Consistency in Administration and Response for the Backward Push and Release Test: A Clinical Assessment of Postural Responses.
Employment as a health promotion intervention for persons with multiple sclerosis.
Potassium channel KIR4.1-specific antibodies in children with acquired demyelinating CNS disease.
Pages
« first
‹ previous
…
246
247
248
249
250
251
252
253
254
…
next ›
last »